We are a provider of medical solutions enabled by artificial intelligence. We are committed to using artificial intelligence technology to enable the medical industry to commercialize medical artificial intelligence solutions on a large scale in China. Our products and solutions support a variety of medical services from health risk warning, early screening, auxiliary diagnosis and treatment, as well as evaluation of treatment effects, post-diagnosis management and chronic disease management. Specifically, we provide (i) primary care services to assist primary care physicians to improve service capabilities; (ii) hospital services to help hospitals improve the efficiency of hospitals and physicians; (iii) patient services to improve the quality of health services enjoyed by patients (including outpatients, inpatients in medical institutions, patients discharged from home, and other individual customers); and (iv) regional management platform solutions to assist regional management agencies in carrying out comprehensive data-driven management and effective deployment of health insurance funds. Through products and solutions for such ancillary medical services, we are committed to promoting human-computer coupling diagnosis and treatment models and contributing to China's healthcare reform. According to Frost & Sullivan, our 2023 revenue scale ranked first in China's medical artificial intelligence industry, with a market share of 5.9%.
No Data